{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:28:44Z","timestamp":1777307324103,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jocn.2021.06.040","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T07:36:19Z","timestamp":1625643379000},"page":"131-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Unmasking antibiotic-associated neurological disorders: The underminer in Intensive Care Unit"],"prefix":"10.1016","volume":"91","author":[{"given":"Minjia","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jocn.2021.06.040_b0005","doi-asserted-by":"crossref","first-page":"92","DOI":"10.7326\/0003-4819-101-1-92","article-title":"The neurotoxicity of antibacterial agents","volume":"1011","author":"Snavely","year":"1984","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.jocn.2021.06.040_b0010","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1212\/WNL.0000000000002455","article-title":"Antibiotic-associated encephalopathy","volume":"86","author":"Bhattacharyya","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jocn.2021.06.040_b0015","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/jnnp.57.6.705","article-title":"Antibiotic induced meningitis","volume":"57","author":"River","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2021.06.040_b0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.seizure.2020.08.012","article-title":"Antibiotic-induced epileptic seizures: mechanisms of action and clinical considerations","volume":"81","author":"Wanleenuwat","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.jocn.2021.06.040_b0025","first-page":"692","article-title":"Penicillin convulsions; the convulsive effects of penicillin applied to the cerebral cortex of monkey and man","volume":"81","author":"Walker","year":"1945","journal-title":"Surgery Gynecol Obstetr"},{"issue":"4","key":"10.1016\/j.jocn.2021.06.040_b0030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0028-3908(89)90030-0","article-title":"Epileptogenic activity of some beta-lactam derivatives: structure-activity relationship","volume":"28","author":"De Sarro","year":"1989","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.jocn.2021.06.040_b0035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1528-1157.1983.tb04913.x","article-title":"Epileptogenic activity of cephalosporins in rats and their structure-activity relationship","volume":"24","author":"Kamei","year":"1983","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.jocn.2021.06.040_b0040","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/AAC.39.1.232","article-title":"Relationship between structure and convulsant properties of some beta-lactam antibiotics following intracerebroventricular microinjection in rats","volume":"39","author":"De Sarro","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jocn.2021.06.040_b0045","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/27.4.405","article-title":"Neurotoxicity of beta-lactam antibiotics: predisposing factors and pathogenesis","volume":"274","author":"Schliamser","year":"1991","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.jocn.2021.06.040_b0050","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s40264-017-0578-2","article-title":"Neurological adverse effects attributable to beta-lactam antibiotics: a literature review","volume":"40","author":"Deshayes","year":"2017","journal-title":"Drug Saf"},{"issue":"4","key":"10.1016\/j.jocn.2021.06.040_b0055","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.jaip.2017.11.034","article-title":"Drug-induced aseptic meningitis: a possible T-cell-mediated hypersensitivity","volume":"6","author":"Castagna","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.jocn.2021.06.040_b0060","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jocn.2010.07.122","article-title":"Amoxicillin-induced acute aseptic meningitis","volume":"18","author":"Prieto-Gonzalez","year":"2011","journal-title":"J Clin Neurosci"},{"issue":"3","key":"10.1016\/j.jocn.2021.06.040_b0065","doi-asserted-by":"crossref","first-page":"248","DOI":"10.18176\/jiaci.0380","article-title":"Amoxicillin-induced aseptic meningitis: 2 case reports and appraisal of the literature","volume":"29","author":"Alarc\u00f3n","year":"2019","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"9","key":"10.1016\/j.jocn.2021.06.040_b0070","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1212\/WNL.57.9.1734","article-title":"Amoxicillin-induced aseptic meningitis","volume":"57","author":"Wittmann","year":"2001","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.jocn.2021.06.040_b0075","doi-asserted-by":"crossref","first-page":"783","DOI":"10.7164\/antibiotics.33.783","article-title":"Ro 13\u20139904\/001, a novel potent and long-acting parenteral cephalosporin","volume":"33","author":"Reiner","year":"1980","journal-title":"J Antibiot"},{"issue":"12","key":"10.1016\/j.jocn.2021.06.040_b0080","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1345\/aph.1L307","article-title":"Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring","volume":"42","author":"Grill","year":"2008","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.jocn.2021.06.040_b0085","doi-asserted-by":"crossref","first-page":"R264","DOI":"10.1186\/cc13094","article-title":"Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy","volume":"17","author":"Fugate","year":"2013","journal-title":"Critical Care (London, England)"},{"issue":"9","key":"10.1016\/j.jocn.2021.06.040_b0090","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/cid\/ciz857","article-title":"Ceftaroline-associated encephalopathy in patients with severe renal impairment","volume":"70","author":"Martin","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jocn.2021.06.040_b0095","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13054-017-1856-1","article-title":"Cefepime-induced neurotoxicity: a systematic review","volume":"21","author":"Payne","year":"2017","journal-title":"Critical Care (London, England)"},{"issue":"5","key":"10.1016\/j.jocn.2021.06.040_b0100","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/jac\/dks012","article-title":"Blood and CSF monitoring of cefepime-induced neurotoxicity: nine case reports","volume":"67","author":"Durand-Maugard","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.jocn.2021.06.040_b0105","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1093\/jac\/dkx209","article-title":"Too much of a good thing: a retrospective study of beta-lactam concentration-toxicity relationships","volume":"72","author":"Imani","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.jocn.2021.06.040_b0110","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.410370617","article-title":"Cephalosporin-induced recurrent aseptic meningitis","volume":"37","author":"Creel","year":"1995","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.jocn.2021.06.040_b0115","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cmi.2017.01.005","article-title":"Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study","volume":"23","author":"Huwyler","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.jocn.2021.06.040_b0120","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1128\/AAC.01595-08","article-title":"High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function","volume":"54","author":"Lamoth","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jocn.2021.06.040_b0125","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmi.2019.06.028","article-title":"Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort study","volume":"26","author":"Boschung-Pasquier","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.jocn.2021.06.040_b0130","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1046\/j.1528-1157.2001.34701.x","article-title":"Seizures in the critically ill: the role of imipenem","volume":"42","author":"Koppel","year":"2001","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.jocn.2021.06.040_b0135","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/jac\/dku111","article-title":"The risk of seizures among the carbapenems: a meta-analysis","volume":"69","author":"Cannon","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jocn.2021.06.040_b0140","doi-asserted-by":"crossref","unstructured":"R. Owens An overview of harms associated with beta-lactam antimicrobials: where do the carbapenems fit in? Critical Care 2008:S3. (London, England) 10.1186\/cc6819.","DOI":"10.1186\/cc6819"},{"issue":"1","key":"10.1016\/j.jocn.2021.06.040_b0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/45.1.5","article-title":"Neurotoxicity of carbapenem antibiotics: consequences for their use in bacterial meningitis","volume":"45","author":"Norrby","year":"2000","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.jocn.2021.06.040_b0150","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0002-9343(88)90071-X","article-title":"Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem\/cilastatin","volume":"84","author":"Calandra","year":"1988","journal-title":"Am J Med"},{"issue":"suppl B","key":"10.1016\/j.jocn.2021.06.040_b0155","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/jac\/26.suppl_B.219","article-title":"Central nervous system toxicity of quinolones: human and animal findings","volume":"26","author":"Christ","year":"1990","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.jocn.2021.06.040_b0160","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5414\/CPP47303","article-title":"Ciprofloxacin-associated seizures in a patient with underlying thyrotoxicosis: case report and literature review","volume":"47","author":"Agbaht","year":"2009","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jocn.2021.06.040_b0165","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10072-009-0027-9","article-title":"Levofloxacin-induced delirium","volume":"30","author":"Slobodin","year":"2009","journal-title":"Neurol Sci"},{"issue":"10","key":"10.1016\/j.jocn.2021.06.040_b0170","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00228-009-0717-5","article-title":"Seizures associated with levofloxacin: case presentation and literature review","volume":"65","author":"Bellon","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.jocn.2021.06.040_b0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000057838","article-title":"History of quinolones and their side effects","volume":"47","author":"Rubinstein","year":"2001","journal-title":"Chemotherapy"},{"issue":"9","key":"10.1016\/j.jocn.2021.06.040_b0180","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1128\/AAC.37.9.1764","article-title":"Involvement of inhibitory and excitatory neurotransmitters in levofloxacin- and ciprofloxacin-induced convulsions in mice","volume":"37","author":"Akahane","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.jocn.2021.06.040_b0185","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1128\/AAC.42.7.1831","article-title":"Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model","volume":"42","author":"Schmuck","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.jocn.2021.06.040_b0190","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0002-9343(89)80620-5","article-title":"Eosinophilic meningitis associated with ciprofloxacin","volume":"87","author":"Asperilla","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.jocn.2021.06.040_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00764","article-title":"Blood-brain barrier More contributor to disruption of central nervous system homeostasis than victim in neurological disorders","volume":"14","author":"Xiao","year":"2020","journal-title":"Front Neurosci"},{"issue":"2","key":"10.1016\/j.jocn.2021.06.040_b0200","doi-asserted-by":"crossref","first-page":"E40","DOI":"10.1111\/hdi.12687","article-title":"Hemodialysis for treatment of levofloxacin-induced neurotoxicity","volume":"23","author":"Idrees","year":"2019","journal-title":"Hemodial Int"},{"issue":"8","key":"10.1016\/j.jocn.2021.06.040_b0205","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1128\/AAC.00672-13","article-title":"Ciprofloxacin-induced psychosis","volume":"57","author":"Ben-Chetrit","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"6087","key":"10.1016\/j.jocn.2021.06.040_b0210","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/bmj.2.6087.610","article-title":"Metronidazole neuropathy","volume":"2","author":"Bradley","year":"1977","journal-title":"Br Med J"},{"issue":"4","key":"10.1016\/j.jocn.2021.06.040_b0215","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s10072-019-04091-z","article-title":"Persistent dystonia and basal ganglia involvement following metronidazole induced encephalopathy","volume":"41","author":"Omrani","year":"2020","journal-title":"Neurol Sci"},{"issue":"9","key":"10.1016\/j.jocn.2021.06.040_b0220","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2176\/nmc.cr.2018-0107","article-title":"Metronidazole induced encephalopathy mimicking an acute ischemic stroke event","volume":"58","author":"Takada","year":"2018","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"5","key":"10.1016\/j.jocn.2021.06.040_b0225","first-page":"409","article-title":"Convulsions associated with high cumulative doses of metronidazole","volume":"16","author":"Halloran","year":"1982","journal-title":"Drug Intel Clin Pharm"},{"issue":"3","key":"10.1016\/j.jocn.2021.06.040_b0230","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijantimicag.2017.08.033","article-title":"Clinical relevance of metronidazole and peripheral neuropathy: a systematic review of the literature","volume":"51","author":"Goolsby","year":"2018","journal-title":"Int J Antimicrob Agents"},{"issue":"24","key":"10.1016\/j.jocn.2021.06.040_b0235","doi-asserted-by":"crossref","first-page":"11731","DOI":"10.1016\/S0021-9258(18)60872-5","article-title":"Generation of nitro radical anions of some 5-nitrofurans, 2- and 5-nitroimidazoles by norepinephrine, dopamine, and serotonin. A possible mechanism for neurotoxicity caused by nitroheterocyclic drugs","volume":"262","author":"Rao","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jocn.2021.06.040_b0240","unstructured":"Hern\u00e1ndez Ceruelos A R-QL, Ruvalcaba Ledezma JC, L\u00f3pez Contreras L. Therapeutic uses of metronidazole and its side effects: an update. Eur Rev Med Pharmacol Sci. 2019;231(1):397-401."},{"issue":"2","key":"10.1016\/j.jocn.2021.06.040_b0245","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0003-9861(87)90577-7","article-title":"Enzymatic conversion of the antibiotic metronidazole to an analog of thiamine","volume":"257","author":"Alston","year":"1987","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jocn.2021.06.040_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2020.03.002","article-title":"Mechanistic exploration of quercetin against metronidazole induced neurotoxicity in rats: possible role of nitric oxide isoforms and inflammatory cytokines","volume":"79","author":"Chaturvedi","year":"2020","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/j.jocn.2021.06.040_b0255","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1148\/radiol.2019171079","article-title":"Case 271: metronidazole-induced encephalopathy","volume":"293","author":"Sun","year":"2019","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.jocn.2021.06.040_b0260","first-page":"1615","article-title":"MR imaging and diffusion-weighted imaging changes in metronidazole (Flagyl)-induced cerebellar toxicity","volume":"24","author":"Heaney","year":"2003","journal-title":"AJNR Am J Neuroradiol"},{"issue":"9","key":"10.1016\/j.jocn.2021.06.040_b0265","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3174\/ajnr.A0655","article-title":"MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings","volume":"28","author":"Kim","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jocn.2021.06.040_b0270","doi-asserted-by":"crossref","unstructured":"Daneman N, Cheng Y, Gomes T, Guan J, Mamdani MM, Saxena FE et al. Metronidazole-associated neurologic events: a nested-case control study. Clin Infect Dis. 2020. doi:10.1093\/cid\/ciaa395.","DOI":"10.1093\/cid\/ciaa395"},{"issue":"1","key":"10.1016\/j.jocn.2021.06.040_b0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-018-9147-6","article-title":"Metronidazole-induced encephalopathy: a systematic review","volume":"267","author":"Sorensen","year":"2020","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.jocn.2021.06.040_b0280","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12883-019-1278-6","article-title":"A case of methylprednisolone treatment for metronidazole-induced encephalopathy","volume":"19","author":"Li","year":"2019","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jocn.2021.06.040_b0285","doi-asserted-by":"crossref","unstructured":"Niederman M, Mandell L, Anzueto A, Bass J, Broughton W, Campbell G et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163(7):1730-54. doi:10.1164\/ajrccm.163.7.at1010.","DOI":"10.1164\/ajrccm.163.7.at1010"},{"issue":"5","key":"10.1016\/j.jocn.2021.06.040_b0290","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/106002809502900506","article-title":"Delirium probably induced by clarithromycin in a patient receiving fluoxetine","volume":"29","author":"Pollak","year":"1995","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.jocn.2021.06.040_b0295","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1183\/09031936.06.00039006","article-title":"Delirium induced by clarithromycin in a patient with community-acquired pneumonia","volume":"28","author":"Vicente de Vera","year":"2006","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jocn.2021.06.040_b0300","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/jac\/dkl480","article-title":"Clarithromycin monotherapy-induced delirium","volume":"59","author":"Ozsoylar","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jocn.2021.06.040_b0305","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1152\/jn.00134.2016","article-title":"Clarithromycin increases neuronal excitability in CA3 pyramidal neurons through a reduction in GABAergic signaling","volume":"117","author":"Bichler","year":"2017","journal-title":"J Neurophysiol"},{"issue":"7","key":"10.1016\/j.jocn.2021.06.040_b0310","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1177\/0269881113515062","article-title":"Improvement in daytime sleepiness with clarithromycin in patients with GABA-related hypersomnia: clinical experience","volume":"28","author":"Trotti","year":"2014","journal-title":"J Psychopharmacol (Oxford, England)"},{"issue":"1","key":"10.1016\/j.jocn.2021.06.040_b0315","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00004714-200202000-00012","article-title":"Antimicrobial-induced mania (antibiomania): a review of spontaneous reports","volume":"22","author":"Abouesh","year":"2002","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.jocn.2021.06.040_b0320","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1086\/520248","article-title":"Central nervous system disturbances following clarithromycin ingestion","volume":"29","author":"Geiderman","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jocn.2021.06.040_b0325","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jocn.2010.08.014","article-title":"Clarithromycin-induced neurotoxicity in adults","volume":"18","author":"Bandettini di Poggio","year":"2011","journal-title":"J Clin Neurosci"},{"issue":"4","key":"10.1016\/j.jocn.2021.06.040_b0330","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00004850-199707000-00007","article-title":"Carbamazepine toxicity induced by clarithromycin coadministration in psychiatric patients","volume":"12","author":"Yasui","year":"1997","journal-title":"Int Clin Psychopharmacol"},{"issue":"11","key":"10.1016\/j.jocn.2021.06.040_b0335","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.clinthera.2014.09.020","article-title":"Neurotoxicity with antimicrobials in the elderly: a review","volume":"36","author":"Mattappalil","year":"2014","journal-title":"Clin Ther"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821003350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821003350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:26:57Z","timestamp":1760822817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586821003350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":67,"alternative-id":["S0967586821003350"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2021.06.040","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unmasking antibiotic-associated neurological disorders: The underminer in Intensive Care Unit","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2021.06.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}